IP Library Granted Patent US 8,476,429
Granted Patent B2
US 8,476,429 · App. 13/455,486 · Granted Jul 2, 2013

Tri-, tetra-substituted-3-aminopyrrolidine derivative

Inventors: Hisashi Takahashi (Edogawa-ku, JP); Hiroaki Inagaki (Edogawa-ku, JP); Satoshi Komoriya (Edogawa-ku, JP); Makoto Takemura (Edogawa-ku, JP); Rie Miyauchi (Edogawa-ku, JP)
Assignee: Daiichi Sankyo Company, Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,476,429
App. No.
13/455,486
Granted
Jul 2, 2013
Kind
B2
Abstract

An intermediate for production of a quinolone synthetic antibacterial agent and a therapeutic agent for an infection which exhibit broad spectrum and strong antibacterial activity for both Gram positive and Gram negative bacteria.

Claims (22)

1. A tetra-substituted 3-aminopyrrolidinyl compound or a salt thereof which is substituted at position 3 and 4 having the formula:

wherein

R 11 and R 21 , each indepentyl represents hydrogen atom or a protective group of amino group;

R 3 represents an alkyl group containing 1 to 6 carbon atoms, which being optionally substituted with halogen atom;

R 4 and R 5 together represent a 3-membered cyclic structure including the carbon atom shared by R 4 and R 5 to form a spirocyclic structure with the pyrrolidine ring;

R 6 and R 7 , each represents hydrogen atom.

2. The compound, or a salt thereof according to claim 1 , wherein R 3 is methyl group.

3. The compound, or a salt thereof according to claim 2 , wherein the protective group of amino group is selected from a group of alkoxycarbonyl groups, aralkyloxycarbonyl groups, acyl groups, alkyl groups or aralkyl groups, ethers and (alkyl and/or aralkyl)-substituted silyl groups.

4. The compound, or a salt thereof according to claim 2 , wherein the protective group of amino group is selected from a group of tertiary butlxycarbonyl group, 2,2,2-trichloroethoxycarbonyl group, benzyloxycarbonyl group, paramethoxybenzyloxycarbonyl group, paranitrobenzyloxycarbonyl group, acetyl group, methoxyacetyl group, trifluoroacetyl group, chloroacetyl group, pivaloyl group, formyl group, and benzoyl group, tertiary butyl group, benzyl group, paranitrobenzyl group, paramethoxybenzyl group, and triphenylmethyl group, methoxymethyl group, tertiary butoxymethyl group, tetrahydropyranyl group, 2,2,2-trichloroethoxymethyl group, trimethylsilyl group, isopropyldimethylsilyl group, tertiary butyldimethylsilyl group, tribenzylsilyl group, and tertiary butyldiphenylsilyl group.

5. A tetra-substituted 3-aminopyrrolidinyl compound or a salt thereof which is substituted at position 3 and 4 having the formula:

wherein

R 11 and R 21 , each indepentyl represents hydrogen atom or a protective group of amino group;

R 3 represents an alkyl group containing 1 to 6 carbon atoms, which being optionally substituted with halogen atom;

R 4 and R 5 together represent a 3-membered cyclic structure including the carbon atom shared by R 4 and R 5 to form a spirocyclic structure with the pyrrolidine ring;

R 6 and R 7 , each represents hydrogen atom.

6. The compound, or a salt thereof according to claim 5 , wherein R 3 is methyl group.

7. The compound, or a salt thereof according to claim 6 , wherein the protective group of amino group is selected from a group of alkoxycarbonyl groups, aralkyloxycarbonyl groups, acyl groups, alkyl groups or aralkyl groups, ethers and (alkyl and/or aralkyl)-substituted silyl groups.

8. The compound, or a salt thereof according to claim 6 , wherein the protective group of amino group is selected from a group of tertiary butlxycarbonyl group, 2,2,2-trichloroethoxycarbonyl group, benzyloxycarbonyl group, paramethoxybenzyloxycarbonyl group, paranitrobenzyloxycarbonyl group, acetyl group, methoxyacetyl group, trifluoroacetyl group, chloroacetyl group, pivaloyl group, formyl group, and benzoyl group, tertiary butyl group, benzyl group, paranitrobenzyl group, paramethoxybenzyl group, and triphenylmethyl group, methoxymethyl group, tertiary butoxymethyl group, tetrahydropyranyl group, 2,2,2-trichloroethoxymethyl group, trimethylsilyl group, isopropyldimethylsilyl group, tertiary butyldimethylsilyl group, tribenzylsilyl group, and tertiary butyldiphenylsilyl group.

9. 5-Benzyl-7-(tert-butoxycarbonylamino)-7-methyl-5-azaspiro[2.4]heptane or a salt thereof.

10. (+)- or (−)-5-Benzyl-7-(tert-butoxycarbonylamino)-7-methyl-5-azaspiro[2.4]heptane or a salt thereof.

11. 7-(tert-butoxycarbonylamino)-7-methyl-5-azaspiro[2.4]heptane or a salt thereof.

12. (+)- or (−)-7-(tert-butoxycarbonylamino)-7-methyl-5-azaspiro[2.4]heptane or a salt thereof.

Assignments (1)
MERGER Recorded May 14, 2013
From: DAIICHI PHARMACEUTICAL CO., LTD.
To: DAIICHI SANKYO COMPANY, LIMITED
Reel/Frame 030416/0182 →
Priority Claims (3)
JP 2005-146386 · May 19, 2005 · national
JP 2005-344514 · Nov 29, 2005 · national
JP 2006-080629 · Mar 23, 2006 · national
Continuity (3)
Division 12422726 · Apr 13, 2009
Division 11413153 · Apr 28, 2006
Related Publication 20120232288A1 · Sep 13, 2012